✦ LIBER ✦

Improving prognosis in NIDDM patients

✍ Scribed by Carl Erik Mogensen; Robert Turner; Christian Berne; Rudy Bilous

Publisher: Springer
Year: 1996
Tongue: English
Weight: 8 KB
Volume: 39
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s001250050611

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Troglitazone, an insulin action enhancer

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients

✍ S. Kumar; A. J. M. Boulton; H. Beck-Nielsen; F. Berthezene; M. Muggeo; B. Persso 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 964 KB

The effects of troglitazone, a novel thiazolidinedione, in non-insulin-dependent diabetic (NIDDM) patients were studied in a double-blind, parallel-group, placebo-controlled, dose-ranging trial. A total of 330 patients (63 % male), mean age 57 years (range 39-72), with two fasting capillary blood gl

Protein C activation in NIDDM patients

✍ E. C. Gabazza; H. Takeya; H. Deguchi; Y. Sumida; O. Taguchi; K. Murata; K. Nakat 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 71 KB

Glomerular hyperfiltration in microalbum

Glomerular hyperfiltration in microalbuminuric NIDDM patients

✍ P. Vedel; J. Obel; F. S. Nielsen; L. E. Bang; T. L. Svendsen; O. B. Pedersen; H. 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 48 KB

Mitochondrial gene defects in patients w

Mitochondrial gene defects in patients with NIDDM

✍ J. C. Alcolado; A. Majid; M. Brockington; M. G. Sweeney; R. Morgan; A. Rees; A. 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 664 KB

Improving prognosis for malignant melano

Improving prognosis for malignant melanoma in Britain

✍ B. A. Taylor; Professor L. E. Hughes; G. T. Williams 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 2 views

Improved prognosis in disseminated histi

Improved prognosis in disseminated histiocytosis

✍ Smith, Peter J. ;Ekert, Henry ;Campbell, P. E. 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

## Abstract The prognosis for children with disseminated histiocytosis, previously considered poor, has improved dramatically with the application of modern principles of chemotherapy. Fourteen children with histiocytosis were staged clinically as follows: those without organ dysfunction, stage I;